연구동향
이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.
164편 검색→153편 판독→62편 선별 (관련도 0.5 이상)
질문과 PubMed 검색식 보기
질문: CYP2D6 gene polymorphism and risk of Parkinson disease and Alzheimer disease
(CYP2D6[tiab] OR "cytochrome P450 2D6"[tiab] OR CYP2D6*[tiab]) AND (polymorphism[tiab] OR polymorphisms[tiab] OR variant[tiab] OR variants[tiab] OR genotype[tiab] OR allele[tiab]) AND (("Parkinson disease"[tiab] OR Parkinson[tiab] OR parkinsonian[tiab]) OR ("Alzheimer disease"[tiab] OR Alzheimer[tiab] OR "Alzheimer's"[tiab]))출판 연도
선별된 62편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.
주제별 논문
주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.
01mutant · debrisoquine22편
- 0.94
Woo SI, Kim JW, Seo HG et al. · Psychiatry and clinical neurosciences · 2001
- 0.94
No association between CYP2D6 polymorphism and Alzheimer's disease in an Italian population
Scordo MG, Dahl ML, Spina E et al. · Pharmacological research · 2006
- 0.93
Cervilla JA, Russ C, Holmes C et al. · Biological psychiatry · 1999
- 0.93
Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease
Smith CA, Gough AC, Leigh PN et al. · Lancet (London, England) · 1992
- 0.92
Cytochrome P4502D6 (debrisoquine 4-hydroxylase) and Parkinson's disease in Chinese and Caucasians
Ho SL, Kung MH, Li LS et al. · European journal of neurology · 1999
- 0.92
Debrisoquine hydroxylase and Parkinson's disease
Kondo I, Kanazawa I · Advances in neurology · 1993
- 0.92
Mutant debrisoquine hydroxylation genes in Parkinson's disease
Armstrong M, Daly AK, Cholerton S et al. · Lancet (London, England) · 1992
- 0.91
A novel cytochrome P-450IID6 mutant gene associated with Parkinson's disease
Tsuneoka Y, Matsuo Y, Iwahashi K et al. · Journal of biochemistry · 1993
- 0.91
CYP2D6 polymorphism in Parkinson's disease: the Rotterdam Study
Harhangi BS, Oostra BA, Heutink P et al. · Movement disorders : official journal of the Movement Disorder Society · 2001
- 0.90
Genetic polymorphism and Parkinson's disease in Taiwan: study of debrisoquine 4-hydroxylase (CYP2D6)
Lo HS, Chen CH, Hogan EL et al. · Journal of the neurological sciences · 1998
- 0.90
Nicholl DJ, Bennett P, Ramsden DB et al. · European journal of neurology · 1995
- 0.89
Golab-Janowska M, Honczarenko K, Gawronska-Szklarz B et al. · Neurologia i neurochirurgia polska · 2007
- 0.89
Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease
Plante-Bordeneuve V, Davis MB, Maraganore DM et al. · Journal of neurology, neurosurgery, and psychiatry · 1994
- 0.89
Genetic analysis of the CYP2D6 gene in patients with Parkinson's disease
Tsuneoka Y, Matsuo Y, Ichikawa Y et al. · Metabolism: clinical and experimental · 1998
- 0.89
The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's disease
Saitoh T, Xia Y, Chen X et al. · Annals of neurology · 1995
- 0.88
Rarity of debrisoquine hydroxylase gene polymorphism in Chinese patients with Parkinson's disease
Pang CP, Zhang J, Woo J et al. · Movement disorders : official journal of the Movement Disorder Society · 1998
- 0.86
Is there a genetic susceptibility locus for Parkinson's disease on chromosome 22q13?
Wilhelmsen K, Mirel D, Marder K et al. · Annals of neurology · 1997
- 0.85
Akhmedova SN, Pushnova EA, Yakimovsky AF et al. · Biochemical and molecular medicine · 1995
- 0.83
The CYP2D6B allele is associated with a milder synaptic pathology in Alzheimer's disease
Chen X, Xia Y, Alford M et al. · Annals of neurology · 1995
- 0.76
Chen X, Xia Y, Gresham LS et al. · Neurology · 1996
- 0.59
Murphy GMJ, Yang L, Yesavage J et al. · Neuroscience letters · 1996
- 0.51
Furuno T, Kawanishi C, Iseki E et al. · Psychiatry and clinical neurosciences · 2001
02odds · confidence interval18편
- 0.94
Anwarullah, Aslam M, Badshah M et al. · Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2017
- 0.92
McCann SJ, Pond SM, James KM et al. · Journal of the neurological sciences · 1997
- 0.92
Genotyping of CYP2D6 in Parkinson's disease
Stefanovic M, Topic E, Ivanisevic AM et al. · Clinical chemistry and laboratory medicine · 2000
- 0.91
CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease
Elbaz A, Levecque C, Clavel J et al. · Annals of neurology · 2004
- 0.90
Polymorphism in environment responsive genes and association with Parkinson disease
Singh M, Khan AJ, Shah PP et al. · Molecular and cellular biochemistry · 2008
- 0.89
Absence of effect of seven functional mutations in the CYP2D6 gene in Parkinson's disease
Joost O, Taylor CA, Thomas CA et al. · Movement disorders : official journal of the Movement Disorder Society · 1999
- 0.89
Genetic predisposition to Parkinson's disease: CYP2D6 and HFE in the Faroe Islands
Halling J, Petersen MS, Grandjean P et al. · Pharmacogenetics and genomics · 2008
- 0.89
Maraganore DM, Farrer MJ, Hardy JA et al. · Movement disorders : official journal of the Movement Disorder Society · 2000
- 0.89
Parkinson's disease, CYP2D6 polymorphism, and age
Payami H, Lee N, Zareparsi S et al. · Neurology · 2001
- 0.88
Santt O, Baranova H, Albuisson E et al. · European journal of neurology · 2004
- 0.88
CYP2D6 allelic frequencies in young-onset Parkinson's disease
Sandy MS, Armstrong M, Tanner CM et al. · Neurology · 1996
- 0.74
Vilar R, Coelho H, Rodrigues E et al. · European journal of neurology · 2007
- 0.64
Genetic and environmental risk factors for Parkinson's disease in a Chinese population
Chan DK, Woo J, Ho SC et al. · Journal of neurology, neurosurgery, and psychiatry · 1998
- 0.62
CYP2D6*4 allele polymorphism increases the risk of Parkinson's disease: evidence from meta-analysis
Lu Y, Mo C, Zeng Z et al. · PloS one · 2013
- 0.61
Parkinson's disease and CYP2D6 polymorphism in Asian populations: A meta-analysis
Persad AS, Stedeford T, Tanaka S et al. · Neuroepidemiology · 2003
- 0.61
Gene-environment interactions in parkinsonism and Parkinson's disease: the Geoparkinson study
Dick FD, De Palma G, Ahmadi A et al. · Occupational and environmental medicine · 2007
- 0.55
Quantitative assessment of CYP2D6 polymorphisms and risk of Alzheimer's disease: a meta-analysis
Lu Y, Qin X, Li S et al. · Journal of the neurological sciences · 2014
- 0.52
Rostami-Hodjegan A, Lennard MS, Woods HF et al. · Pharmacogenetics · 1998
03mutations · frequencies11편
- 0.93
Association of CYP2D microsatellite polymorphism with Lewy body variant of Alzheimer's disease
Tanaka S, Chen X, Xia Y et al. · Neurology · 1998
- 0.92
Association between the oxidative polymorphism and early onset of Parkinson's disease
Agundez JA, Jimenez-Jimenez FJ, Luengo A et al. · Clinical pharmacology and therapeutics · 1995
- 0.92
Gasser T, Muller-Myhsok B, Supala A et al. · Journal of neurology, neurosurgery, and psychiatry · 1996
- 0.92
Mutation frequencies of the cytochrome CYP2D6 gene in Parkinson disease patients and in families
Lucotte G, Turpin JC, Gerard N et al. · American journal of medical genetics · 1996
- 0.92
CYP2D6 polymorphism and Parkinson's disease susceptibility
Sabbagh N, Brice A, Marez D et al. · Movement disorders : official journal of the Movement Disorder Society · 1999
- 0.91
Bordet R, Broly F, Destee A et al. · Clinical neuropharmacology · 1996
- 0.89
Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's disease
Kurth MC, Kurth JH · American journal of medical genetics · 1993
- 0.88
Bordet R, Broly F, Destee A et al. · Clinical neuropharmacology · 1994
- 0.87
No association between familial Alzheimer disease and cytochrome P450 polymorphisms
Yamada H, Dahl ML, Viitanen M et al. · Alzheimer disease and associated disorders · 1998
- 0.85
Nicholl DJ, Bennett P, Hiller L et al. · Neurology · 1999
- 0.62
A CYPome-wide study reveals new potential players in the pathogenesis of Parkinson's disease
Hartz P, Fehlmann T, Wagenpfeil G et al. · Frontiers in pharmacology · 2022
04cytochrome p450 · 2d69편
- 0.94
Atkinson A, Singleton AB, Steward A et al. · Pharmacogenetics · 1999
- 0.93
Singh M, Khanna VK, Shukla R et al. · Disease markers · 2010
- 0.91
Bon MA, Jansen Steur EN, de Vos RA et al. · Neuroscience letters · 1999
- 0.90
Gene-gene and gene-environment interaction on the risk of Parkinson's disease
Singh NK, Banerjee BD, Bala K et al. · Current aging science · 2014
- 0.86
Singh NK, Banerjee BD, Bala K et al. · Journal of geriatric psychiatry and neurology · 2014
- 0.83
Bialecka M, Klodowska-Duda G, Honczarenko K et al. · Parkinsonism & related disorders · 2007
- 0.81
Quantitative and causal analysis for inflammatory genes and the risk of Parkinson's disease
Yi M, Li J, Jian S et al. · Frontiers in immunology · 2023
- 0.60
Mann A, Miksys SL, Gaedigk A et al. · Neurobiology of aging · 2012
- 0.54
Factor SA, Steenland NK, Higgins DS et al. · Journal of neurology, neurosurgery, and psychiatry · 2011
05pharmacogenetic · drug1편
- 0.73
Zuniga-Santamaria T, Perez-Aldana BE, Fricke-Galindo I et al. · Neurology international · 2025
06donepezil · treatment1편
- 0.50
Miranda LFJR, Gomes KB, Silveira JN et al. · Journal of Alzheimer's disease : JAD · 2015